Treatment of Mantle Cell Lymphoma in the Frontline Setting: Are We Ready for a Risk-Adapted Approach?

Mantle cell lymphoma (MCL), a type of B-cell non-Hodgkin lymphoma characterized by the t(11;14)(q13q32) translocation, is a clinically heterogenous disease which can range from indolent to highly aggressive. Numerous prognostic factors have been identified, including blastoid histology, the Mantle C...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammons, Lindsay, Fenske, Timothy S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324979/
https://www.ncbi.nlm.nih.gov/pubmed/35887631
http://dx.doi.org/10.3390/jpm12071134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324979/
https://www.ncbi.nlm.nih.gov/pubmed/35887631
http://dx.doi.org/10.3390/jpm12071134

Ejemplares similares